Prognostic and Clinicopathological Significance of Circular RNA circ-ITCH Expression in Cancer Patients: A Meta-analysis

Table 2

Stratification analysis for the meta-analysis with overall survival (OS) in patients with cancers.

Subgroup	No. of studies	No. of patients	Pooled HR (95% CI)	Heterogeneity
				(%)	value
Cancer type
Prostate cancer	2	416	2.88 (1.89-4.39)	0.0	0.345
Ovarian cancer	4	264	2.70 (1.82-4.02)	0.0	0.720
Others	7	894	2.29 (1.86-2.82)	0.0	0.928
Cutoff value
Median	9	1302	2.45 (2.01-2.98)	0.0	0.894
Others	4	272	2.46 (1.76-3.43)	0.0	0.622
Sample size
>100	5	1067	2.31 (1.85-2.90)	0.0	0.959
<100	8	507	2.64 (2.04-3.41)	0.0	0.766